CXCL1 and colorectal carcinoma: In addition, the anti‐angiogenic receptor tyrosine kinase inhibitor TSU68 suppresses CXCL1 expression in the liver PMN, which is associated with decreased CXCR2+ neutrophil infiltration and subsequent liver metastasis, in a mouse model of CRC [202].